指南与共识肝病

美国胃肠病学协会研究所临床实践更新-专家评议:慢性丙型肝炎抗病毒治疗获得持续病毒学应答患者的照护

American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
指南 / 共识 · Gastroenterology · 2017-03-23

该临床实践更新由美国胃肠病学协会研究所发布,针对慢性丙型肝炎抗病毒治疗后获得持续病毒学应答(SVR)的患者,结合现有证据与专家意见提出照护最佳实践建议。背景指出直接抗病毒药物方案SVR率一般超过90%,SVR与肝硬化、肝功能失代偿、肝移植需求及肝病相关和全因死亡风险降低相关,但部分获SVR者仍有长期进展风险,且指导监测与出院的证据有限。

要点

  • 慢性丙型肝炎直接抗病毒治疗SVR率一般超过90%,SVR与肝硬化、肝功能失代偿、肝移植需求及死亡风险降低相关。
  • 部分获得SVR的患者仍有进展为肝硬化、肝衰竭、肝细胞癌和肝病相关死亡的长期风险。
  • 指导哪些SVR后患者需监测或可出院、监测方法与频率、监测时长的证据有限,本更新以现有证据和专家意见提出最佳实践建议。

核心结论

  • 慢性丙型肝炎抗病毒治疗后获得SVR可降低肝硬化、肝功能失代偿、肝移植需求及肝病相关和全因死亡风险,但部分患者仍有长期进展风险,本临床实践更新以现有证据和专家意见提出SVR后照护的最佳实践建议。

研究设计与样本

  • 美国胃肠病学协会研究所发布的临床实践更新-专家评议,采用现有证据与专家意见生成最佳实践建议。

主要发现

  • 慢性丙型肝炎病毒感染因肝硬化和肝细胞癌并发症而伴随显著患病率和死亡率。
  • 当前全口服直接抗病毒药物方案的SVR率一般超过90%。
  • SVR与肝硬化、肝功能失代偿、肝移植需求以及肝病相关和全因死亡风险降低相关。
  • 部分获得SVR的患者仍面临进展为肝硬化、肝衰竭、肝细胞癌和肝病相关死亡的长期风险。

临床怎么用

  • 本临床实践更新以现有证据和专家意见生成关于获得SVR的慢性丙型肝炎患者照护的最佳实践建议,原文摘要未列出具体推荐条款。

局限性

  • 指导临床医生判断哪些SVR后患者应监测或可出院、如何监测及选用哪些检查、监测频率和监测时长的证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic hepatitis C virus infection is well-recognized as a common blood-borne infection with global public health impact affecting 3 to 5 million persons in the United States and more than 170 million persons worldwide. Chronic hepatitis C virus infection is associated with significant morbidity and mortality due to complications of liver cirrhosis and hepatocellular carcinoma. Current therapies with all-oral direct-acting antiviral agents are associated with high rates of sustained virologic response (SVR), generally exceeding 90%. SVR is associated with a reduced risk of liver cirrhosis, hepatic decompensation, need for liver transplantation, and both liver-related and all-cause mortality. However, a subset of patients who achieve SVR will remain at long-term risk for progression to cirrhosis, liver failure, hepatocellular carcinoma, and liver-related mortality. Limited evidence is available to guide clinicians on which post-SVR patients should be monitored vs discharged, how to monitor and with which tests, how frequently should monitoring occur, and for how long. In this clinical practice update, available evidence and expert opinion are used to generate best practice recommendations on the care of patients with chronic hepatitis C virus who have achieved SVR.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Jacobson IM, Lim JK, Fried MW, et al. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection. Gastroenterology. 2017. PMID: 28344022. doi:10.1053/j.gastro.2017.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。